Eidos-Medicine LLC is one of the fastest growing and innovative industries based in Kazan, Russia. The company specializes in design, developing and manufacturing of high-tech medical simulators. The company has started 2012 and by 2015 has reached an annual turnover of over $ 10 million, it is 2018 and now Eidos-Medicine employed more than 130 software developers and more than 200 different specialists and have its own development and manufacturing center. The company represents more than 50% of the Russian of high-tech medical simulators market and supplies medical simulators to customers in of Europe, Asia, USA and CIS countries.
Eidos-Medicine LLC is an acting member of the Cluster of Biological and Medical Technologies of the Skolkovo Foundation is the only company specialized in design and manufacture of high-tech medical training simulators on the territory of the Eurasian Economic Union. The company was awarded All-Russian National Business Award "Business Success 2015", and later initiated and now actively contributes to the scientific and educational simulation center of “Center of Medical Science”(Kazan), approved by Chairman of the Supervisory Board, Agency for Strategic Initiatives of Russia, the President of the Russian Federation Mr. Vladimir Putin.
High performance of medical training simulators developed by Eidos-Medicine LLC was confirmed by multiple tests carried out in Juntendo Tokyo Medical University (Japan) and experts of the world's largest surgical equipment manufacturing company Medtronic-Covidien (USA).
In 2015, an ambitious project aimed at the creation of a high-tech simulation center at the Juntendo Medical University was launched. The project is based on the unique tripartite cooperation of the largest scientific center Riken-Juntendo-Eidos. The center will function according to a unique methodical system developed jointly as part of the tripartite partnership and based on the equipment of Eidos-Medicine LLC. In addition, the partnership will develop a unique rehearsal system for endosurgical operations, which will be implemented as state program of personalized medicine in Japan.